Journal of Diabetes and Its Complications
Volume 25, Issue 6 , Pages 355-361, November 2011

The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA Diabetes Trial☆☆☆

  • William C. Duckworth

      Affiliations

    • Phoenix VA Health Care Center, Phoenix, AZ 85012, USA
    • Corresponding Author InformationCorresponding author. Fax: +1 602 200 6004.
    • ,
  • Carlos Abraira

      Affiliations

    • Miami VA Medical Center, Miami, FL, USA
    • ,
  • Thomas E. Moritz

      Affiliations

    • Hines VA Cooperative Studies Program (CSP) Coordinating Center, Hines, IL, USA
    • ,
  • Stephen N. Davis

      Affiliations

    • Tennessee Valley Health Care System, Nashville, TN, USA
    • ,
  • Nicholas Emanuele

      Affiliations

    • Hines VA Hospital, Hines, IL, USA
    • ,
  • Steven Goldman

      Affiliations

    • Southern Arizona VA Health Care System, Tucson, AZ, USA
    • ,
  • Rodney Hayward

      Affiliations

    • VA Ann Arbor Healthcare System, Ann Arbor, MI, USA
    • ,
  • Grant D. Huang

      Affiliations

    • Cooperative Studies Program Central Office, VA Office of Research and Development, Washington, DC, USA
    • ,
  • Jennifer B. Marks

      Affiliations

    • Miami VA Medical Center, Miami, FL, USA
    • ,
  • Peter D. Reaven

      Affiliations

    • Phoenix VA Health Care Center, Phoenix, AZ 85012, USA
    • ,
  • Domenic J. Reda

      Affiliations

    • Hines VA Cooperative Studies Program (CSP) Coordinating Center, Hines, IL, USA
    • ,
  • Stuart R. Warren

      Affiliations

    • VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, USA
    • ,
  • Franklin J. Zieve

      Affiliations

    • Hunter Holmes McGuire VA Medical Center, Richmond, VA, USA
    • ,
  • for the Investigators of the VADT

Received 15 October 2010; received in revised form 5 October 2011; accepted 7 October 2011. published online 07 November 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ A portion of these data was presented at the June 2009 Annual Meeting of the ADA in New Orleans, LA, USA.

☆☆ This study was supported by the VA Cooperative Studies Program, Department of Veterans Affairs Office of Research and Development. All rights are reserved by the United States Department of Veteran Affairs. All authors have filed conflict-of-interest statements. Additional support was received from the American Diabetes Association and the National Eye Institute of the NIH. Pharmaceutical, other supplies, and financial assistance were provided by GlaxoSmithKline, Novo Nordisk, Roche Diagnostics, Sanofi-Aventis, Amylin, and Kos Pharmaceuticals. The assistance of the co-chairs' coordinators, Susan Collier (Phoenix) and Christina Paul (Miami), in the preparation of this manuscript is gratefully acknowledged. Lizy Thottapurathu (Hines) assisted in the data analysis. Special recognition is given to Rebecca Miller (Phoenix), Georgia Roode (Phoenix), and Janet Fawcett, Ph.D. (Phoenix), for preparing the final draft and for consistent support throughout the study, and to our veterans who participated in and made possible this study.

PII: S1056-8727(11)00125-5

doi:10.1016/j.jdiacomp.2011.10.003

Journal of Diabetes and Its Complications
Volume 25, Issue 6 , Pages 355-361, November 2011

Article Tools

* Image Usage & Resolution